Western blot also showed that in colon cancer cells, overexpression of p300 increased COX-2 expression and acetylation of XRCC5, HAT inhibitor (C646) of p300 decreased COX-2 expression and acetylation of XRCC5. Here, XRCC5 is linked to malignant colon neoplasm.